grade examination neuropathy peripheral pain clinical period screening patient initiation 
higher neuropathy grade peripheral patients ctcae neurotoxicity current ii arm 
ctcae grade nci version neuropathy ongoing infection uln peripheral toxicity 
neuropathy peripheral grade enrollment patient days applicable ahct ctcae initiation 
grade neuropathy fl pain hypertriglyceridemia edema peripheral ae hyperglycemia low 
grades pain neuropathy significant grade days prior enrollment randomization day 
neuropathy grade baseline patients ctcae significant neurosensory time diabetic enrollment 
